Leverage Shares 2X Long UNH Daily ETF

Judge grants Luigi Mangione's request to suppress evidence in UnitedHealth CEO murder case

Bryn Mawr Trust Advisors LLC Reduced Stake in UnitedHealth Group and Announced Dividend

Piper Sandler Raises UnitedHealth Target Price to $403

UnitedHealth Reports Beat-Expectation Q1 Earnings and Raises FY Guidance

UnitedHealth Cuts Most Prior Authorizations, Speeds Payments to Rural Providers

Amesite

InMed Pharmaceuticals

Meiwu Tech

Co-Diagnostics

Phoenix Asia

Generation Income Properties

MetaVia

Rubico

Virax Biolabs

Agilysys

Pinned News

置顶新闻

Zacks Research Issues Optimistic Estimate for UNH Earnings

UNHG

Zacks Research has raised its Q1 2027 earnings estimate for UnitedHealth Group (NYSE:UNH) to $6.87 per share, up from $6.77. The consensus estimate for the full-year earnings is $18.29 per share. Various analysts have given mixed ratings, with an average rating of 'Moderate Buy' and a price target of $381.83. UNH shares opened at $390.44, with a market cap of $354.57 billion.

Market Beat

Unitedhealth

iShares Global Healthcare

Health Care Select Sector SPDR

SPDR S&P Health

iShares US Healthcare Providers

VG Health

Berkshire Hathaway

Berkshire Hathaway B

HSBC

HSBC HOLDINGS

HSBC Holdings Plc

Jefferies Financial

Barclays

Piper Sandler Cos

UBS Group AG

HSBC 5xShortSG241213

GSA Capital Partners LLP increased its stake in UnitedHealth Group (NYSE:UNH) by 203.2% in Q4, owning 6,673 shares valued at $2.2 million. Other institutional investors also raised their holdings. Analysts have upgraded their ratings, with Barclays setting a price target of $373.00. Despite Berkshire Hathaway's exit affecting sentiment, UnitedHealth's recent earnings showed positive results, maintaining a market cap of $354.57 billion.

KeyCorp

Thomson Reuters

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP

BRK.A

BRK.B

Berkshire Hathaway has sold its entire stake in UnitedHealth, realizing a 45% profit as the stock rebounded from $271 to $394 in nine months. New CEO Greg Abel is reshaping the portfolio by reducing exposure to sectors with rising risks, such as healthcare and high-valuation tech. Berkshire initially invested in UnitedHealth during a crisis in 2025 marked by leadership issues and regulatory challenges.

- Berkshire Hathaway completely divested its UnitedHealth stake after a 45% increase in share price from $271 to $394 within nine months.  
- New CEO Greg Abel is restructuring the portfolio to minimize exposure to sectors with increasing risks, particularly healthcare and high-valuation technology.  
- UnitedHealth was acquired by Berkshire during a crisis in 2025 marked by leadership issues, regulatory investigations, and escalating costs.

Berkshire Hathaway exits UnitedHealth stake with 45% gain

Stephens Inc. AR increased its stake in UnitedHealth Group (NYSE:UNH) by 30.2% in Q4, acquiring 9,617 shares, bringing its total to 41,418 shares valued at $13.7 million. Other institutional investors also adjusted their holdings. UnitedHealth's stock opened at $393.65, with a market cap of $357.49 billion and a P/E ratio of 29.73. The company reported $7.23 EPS for the last quarter, exceeding estimates, and declared a quarterly dividend of $2.21.

JPMorgan Chase

Wells Fargo

Truist Financial

Raymond James Financial

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

Stephens Inc. AR Purchases 9,617 Shares of UnitedHealth Group Incorporated $UNH

Phoenix Financial Ltd. increased its holdings in UnitedHealth Group (NYSE:UNH) by 11.8% in Q4, owning 46,959 shares valued at $15.3 million. Other institutional investors also adjusted their positions. Analysts have raised price targets for UNH, with a consensus target of $378.88, reflecting positive sentiment around the stock's fundamentals and recent earnings performance.

Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH

Berkshire Hathaway sold its entire stake in UnitedHealth in Q1 2026, leading to a decline in the insurer's stock. CEO Greg Abel's strategy reflects a shift towards quicker trades, contrasting with Warren Buffett's long-term approach. Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

- Berkshire Hathaway divested its entire UnitedHealth position in Q1 2026, leading to a decline in the insurer's stock.  
- CEO Greg Abel is adopting a strategy of quicker trades and capital redeployment, contrasting with Warren Buffett's long-term investment approach.  
- Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

Berkshire's UnitedHealth exit sends shares lower despite turnaround

10:40 AM EDT, 05/18/2026 (MT Newswires) --Price: 385.14, Change: -8.72, Percent Change: -2.21 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

fidelity

--State Judge in UnitedHealthcare CEO Murder Case Blocks Mangione Backpack Evidence, CNBC Reports

UnitedHealth Group Inc. (NYSE:UNH) shares fell 3.05% in premarket trading after Berkshire Hathaway disclosed it sold its entire stake of about 5 million shares. This divestment comes as UnitedHealth expands its AI initiatives, monitoring employee usage of AI tools and investing $1.5 billion in AI this year. Despite the stock drop, UnitedHealth reported strong Q1 earnings, with adjusted earnings of $7.23, surpassing estimates. The company has seen an 18% increase in stock value over the past month.

benzinga_article

S&P 500

Why Is UnitedHealth Stock Trading Lower On Monday?

REGN

U.S. stock futures fell this morning, with Nasdaq futures down about 100 points. UnitedHealth Group shares dropped 4.6% to $375.51 after Berkshire Hathaway fully diluted its position. Other notable declines include Regeneron Pharmaceuticals down 10.5% to $625.00 and Amtech Systems down 14.6% to $18.00 in pre-market trading.

Regeneron Pharma

iShares US Pharma

NASDAQ Composite Index

Amtech

Li Auto

LI AUTO-W

Icahn Enterprises

Onterris

Source Capital

CapsoVision

JBS NV

Zai Lab

ZAI LAB

Argo Blockchain

Strategy

JBS S.A.

Argo Blockchain Pref Share ARBKL 8.75 11/30/26

Argo Blockchain plc

MicroStrategy Pref Shares MSTR 10.0 Perp

Microstrategy Inc Pref Shares STRC 9.0 Perp

MicroStrategy Pref Shares MSTR 8.0 Perp

UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Futures are down as global bond yields rise, influenced by stalled US/Iran talks and increasing oil prices. S&P futures are down 0.5%, while Nvidia is the only rising member of the Mag 7 ahead of its earnings report. UnitedHealth shares fell 5.3% after Berkshire Hathaway exited its stake. Regeneron Pharmaceuticals dropped 10% due to disappointing trial results. The market is cautious amid geopolitical tensions and expectations of Federal Reserve rate hikes, with strategists adjusting S&P 500 targets in response to rising yields.

- Futures are trading lower as markets react to rising global yields and stalled US/Iran negotiations.  
- The S&P futures are down 0.5%, with significant movements in sectors influenced by geopolitical tensions and earnings expectations, especially for Nvidia.  
- Various economic indicators will be released today, including the NY Fed activity indicator, while rising oil prices continue to elevate inflation concerns globally.

ZeroHedge

Occidental Petroleum

Us Brent Oil

United States Oil Fund LP

iShares US Oil & Gas Expl & Prod

T-Rex 2X Long NVIDIA Daily Target ETF

SPDR O&G Ex & Prd

ISHRS S&P Glb Engy

VanEck Oil Refiners ETF

Pro Ultr Bloomberg Crude Oil

VanEck Oil Services ETF

NVIDIA

Alphabet

Alphabet - C

Microsoft

Apple

Meta Platforms

Amazon

Tesla

Delta Air Lines

Echostar

Rocket Lab

AST SpaceMobile

Citigroup

Morgan Stanley

NVIDIA Corporation

CITIGROUP INC 6.250 NON CUM SER II PFD WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Futures Slide After Bond Yields, Oil Prices Jump Around The Globe

Bryn Mawr Trust Advisors LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 10.4% in Q4, holding 27,789 shares valued at $9.17 million. Other investors also adjusted their positions, with institutional ownership at 87.86%. CEO Patrick Hugh Conway sold 800 shares, decreasing his ownership by 4.3%. UnitedHealth reported Q1 earnings of $7.23 per share, exceeding estimates, and announced a quarterly dividend of $2.21 per share. The stock opened at $379.49, with a market cap of $344.63 billion and a P/E ratio of 28.66.

Bryn Mawr Trust Advisors LLC Trims Position in UnitedHealth Group Incorporated $UNH

Leverage Shares 2X Long UNH Daily ETF(UNHG.US)